The EIF2AK4 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the EIF2AK4 gene in human HT29 colorectal adenocarcinoma epithelial cells. This gene-edited polyclonal pool provides a heterogeneous loss-of-function model, enabling researchers to study the functional consequences of EIF2AK4 (GCN2) ablation without the clonal selection bias inherent to single-cell-derived lines. The polyclonal format captures the average biological effect of target-gene disruption across a mixed cell population, offering a robust starting point for downstream investigations.
The host cell line, HT29, is a well-characterized human colorectal adenocarcinoma cell line derived from a primary colon adenocarcinoma. These cells exhibit epithelial morphology and are widely utilized as an intestinal epithelial model in cancer biology, drug screening, and studies of colorectal cancer pathogenesis. HT29 cells retain features of transformed intestinal epithelium and are commonly employed to investigate tumor cell behavior, including proliferation, differentiation, and response to therapeutic agents.
EIF2AK4 encodes GCN2, a serine/threonine kinase that senses amino acid deprivation via uncharged tRNAs, which are recognized by the GCN1-GCN20 complex. Activated GCN2 phosphorylates eIF2?? at Ser51, attenuating global translation while promoting translation of ATF4 mRNA. ATF4 transcriptionally induces downstream targets such as DDIT3 (CHOP), PPP1R15A (GADD34), and adaptive genes like ASNS and SLC7A11. This GCN2-eIF2??-ATF4 cascade forms a central hub of the integrated stress response (ISR) and exhibits crosstalk with mTOR signaling. While transient ISR activation promotes cellular adaptation, persistent stress can trigger apoptosis through CHOP and GADD34.
In HT29 colorectal cancer cells, EIF2AK4 knockout disrupts this amino acid-sensing machinery, impairing the ISR. Given that solid tumors often encounter nutrient-poor microenvironments, loss of GCN2 may compromise the ability of HT29 cells to adapt to metabolic stress, potentially affecting tumor cell survival, proliferation, and resistance to chemotherapeutics. This knockout polyclonal population therefore provides a physiologically relevant model to dissect how colorectal adenocarcinoma cells rely on GCN2-mediated stress adaptation and to explore ISR dependency in cancer.
Researchers can use this polyclonal knockout pool for functional studies of ISR and amino acid sensing in colorectal cancer, stress granule dynamics, and chemotherapy resistance. Key assays include Western blot for phospho-eIF2?? (Ser51), RT-qPCR for ATF4 and CHOP, viability assays under amino acid starvation, colony formation, drug sensitivity testing with ISR modulators, and tumor xenograft analysis. This tool supports both basic and translational investigations. For inquiries, please contact Ascent Research.
